Moderna's COVID-19 vaccine OK'd in Canada for children aged 6 months and older
Moderna Inc. said Thursday its COVID-19 vaccine Spikevax was approved by Health Canada for use in children aged six months to five years. The biotechnology company said the two-dose regimen for children in that age group is completed in one month, the same as for adults, adolescents and children over five years old. Moderna's vaccine was authorized in the U.S. last month for use in that age group. Moderna's stock, which slumped 5.1% in midday trading, has slipped 1.8% over the past three months... Читать дальше...
